A pair of Bay Area biotech companies have filed IPO plans, but there aren't likely to be any new stock offerings until after the U.S. government shutdown ends.
The Wall Street Journal reported on Wednesday that the partial closure of the U.S. Securities and Exchange Commission is forcing companies that were seeking to list shares in January to delay those plans.
That means the Bay Area IPO drought that started when markets see-sawed violently in November and December is likely to extend to at…
